Johns Hopkins drives $19.4B a year here — and is absorbing a real federal funding crisis
Baltimore's largest anchor institution generates more annual economic impact than most cities' entire downtowns, while living through the most disruptive federal research-funding stretch in its recent history — a genuinely current tension, not a footnote.
Benchmarks in this market
- Qualified biotech & research-adjacent inquiries
- +141%Qualified biotech & research-adjacent inquiries
- Cybersecurity vendor visibility
- +37%Cybersecurity vendor visibility
- CAC on compliance-heavy healthcare funnels
- -24%CAC on compliance-heavy healthcare funnels
Illustrative ranges for engagements of this type, not verified Baltimore-specific client data. Orientation, not a guarantee — your starting point changes the range.
How we work here: Remotely from our San Francisco office, with ET coverage for calls and travel for kickoffs. We don't claim a Baltimore office we don't have.
Clients across every market
What's actually different about the Baltimore metro
Johns Hopkins University and its health system employ more than 22,000 people in Baltimore and generate $19.4 billion in annual economic impact on the city alone — $40 billion statewide, supporting 149,000 Maryland jobs. Johns Hopkins Technology Ventures has spun out 130 startups that have raised $4.4 billion in venture capital, with 43% of that funding staying in Baltimore rather than leaving for other tech hubs. But 2025 and 2026 have been genuinely difficult years for the institution: a $800 million-plus loss in USAID funding triggered the largest layoff round in the university's history in May 2025 — 2,200 positions, including 247 U.S.-based roles — and the university's federal research funding portfolio shrank by more than $500 million for the year, a 43% drop in new and ongoing federal awards. A second wave of cuts hit in June 2026, eliminating 110 more administrative positions. On the cybersecurity side, Baltimore sits inside the Fort Meade corridor alongside the NSA and U.S. Cyber Command, and ZeroFox — genuinely headquartered in Baltimore City, not the surrounding counties where much of the region's cyber cluster actually sits — was taken private in a roughly $350 million deal completed in 2024. Under Armour remains headquartered in the city too, and its own story mirrors the pattern: revenue has declined for two straight fiscal years to $5.0 billion, yet the company is still building a new corporate campus at Baltimore Peninsula for 1,500 employees — betting on the city while working through a real financial restructuring.
Johns Hopkins' funding crisis is real, dated, and ongoing — not a one-time headline
March 2025's $800M USAID cut, May 2025's 2,200-position layoff, a $500M+ full-year shrinkage in federal research funding, and a second 110-position cut in June 2026 form a genuine multi-wave story. Any biotech, research-adjacent, or higher-ed-services company marketing into this ecosystem right now needs to understand that the institution's own budget conversations have fundamentally changed, not assume the funding environment of two years ago still holds.
Baltimore's cybersecurity identity is real but geographically overstated in most content
Much of what gets casually called 'Baltimore cybersecurity' — Tenable, Blackpoint Cyber — actually sits in Howard County (Columbia, Ellicott City), not Baltimore City itself. ZeroFox is the clean, verified Baltimore-headquartered example. A vendor or marketer that gets this geography wrong signals they haven't actually done the research, in a market sophisticated enough to notice.
Under Armour is simultaneously shrinking and doubling down, and both are true
Two straight years of declining revenue and a falling headcount sit alongside active construction of a new 1,500-employee campus at Baltimore Peninsula. Marketing content that only tells the growth half or only the decline half misses the actual, more interesting current reality.
$4.4 billion in Johns Hopkins-spun-out venture capital is a real, underused local asset
130 startups and 43% of their raised capital staying local is a genuine sign of a growing biotech and research-commercialization ecosystem around the university — even while the university's own federal funding contracts, the startup pipeline it has already created keeps generating real, fundable companies.
What usually moves first in Baltimore.
Based on what tends to be the binding constraint for companies in this market. Your audit may point somewhere else — we go where the numbers say.
Industry playbooks relevant in Baltimore
The part clients actually remember.
Not the reports. The uncomfortable conversation that changed the trajectory.
We'd been quietly tracking diversion data for years because it was good practice, not because we thought anyone would pay for it. Turns out the properties we most wanted as clients had been asking every hauler for exactly that, and nobody was answering.
We'd been telling practices we'd get them paid faster for years. Nobody had told us that wasn't actually what was stopping them from switching — the fear of switching itself was, and once we addressed that directly instead of the speed pitch, everything else got easier.
Our counter reps were our entire growth engine for thirty years. Nobody had ever built a version of that relationship that worked online, and it turns out purchasing managers wanted exactly that — they just couldn't find us first.
Baltimore questions, answered straight.
Significantly. Budget conversations inside research institutions right now are more conservative and more scrutinized than they were two years ago, and a sales or marketing motion built for the pre-2025 funding environment will misread how buyers are currently evaluating spend. Positioning around cost-efficiency and grant-cycle flexibility matters more right now than it did previously.
Other markets we work in
Let's look at your numbers.
A free 30-minute teardown of your funnel, ads, and site — run against what actually works in the Baltimore metro. You keep the findings either way.